Withanolide C Inhibits Proliferation of Breast Cancer Cells via Oxidative Stress-Mediated Apoptosis and DNA Damage
Open Access
- 16 September 2020
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 9 (9) , 873
Abstract
Some withanolides, particularly the family of steroidal lactones, show anticancer effects, but this is rarely reported for withanolide C (WHC)—especially anti-breast cancer effects. The subject of this study is to evaluate the ability of WHC to regulate the proliferation of breast cancer cells, using both time and concentration in treatment with WHC. In terms of ATP depletion, WHC induced more antiproliferation to three breast cancer cell lines, SKBR3, MCF7, and MDA-MB-231, than to normal breast M10 cell lines. SKBR3 and MCF7 cells showing higher sensitivity to WHC were used to explore the antiproliferation mechanism. Flow cytometric apoptosis analyses showed that subG1 phase and annexin V population were increased in breast cancer cells after WHC treatment. Western blotting showed that cleaved forms of the apoptotic proteins poly (ADP-ribose) polymerase (c-PARP) and cleaved caspase 3 (c-Cas 3) were increased in breast cancer cells. Flow cytometric oxidative stress analyses showed that WHC triggered reactive oxygen species (ROS) and mitochondrial superoxide (MitoSOX) production as well as glutathione depletion. In contrast, normal breast M10 cells showed lower levels of ROS and annexin V expression than breast cancer cells. Flow cytometric DNA damage analyses showed that WHC triggered γH2AX and 8-oxo-2′-deoxyguanosine (8-oxodG) expression in breast cancer cells. Moreover, N-acetylcysteine (NAC) pretreatment reverted oxidative stress-mediated ATP depletion, apoptosis, and DNA damage. Therefore, WHC kills breast cancer cells depending on oxidative stress-associated mechanisms.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 108-2320-B-037-015-MY3, MOST 108-2314-B-037-080, MOST 109-2314-B-037-018)
- National Sun Yat-sen University-KMU Joint Research Project (#NSYSUKMU 109-I002)
- Chimei-KMU jointed project (109CM-KMU-007)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH104-4R20)
- Kaohsiung Medical University Research Center (KMU-TC108A04)
- Health and welfare surcharge of tobacco products, the Ministry of Health and Welfare, Taiwan, Republic of China (MOHW 109-TDU-B-212-134016)
This publication has 42 references indexed in Scilit:
- Withanolides from the genus Physalis: a review on their phytochemical and pharmacological aspectsJournal of Pharmacy and Pharmacology, 2019
- Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cellsBiochemical and Biophysical Research Communications, 2018
- Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanismsExperimental Cell Research, 2018
- Withaferin A Induces Oxidative Stress-Mediated Apoptosis and DNA Damage in Oral Cancer CellsFrontiers in Physiology, 2017
- Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradationCell Death & Disease, 2015
- Potential Anticancer Properties and Mechanisms of Action of Withanolides2015
- Withaferin A induces apoptosis through the generation of thiol oxidation in human head and neck cancer cellsInternational Journal of Molecular Medicine, 2014
- Golden Berry-Derived 4β-hydroxywithanolide E for Selectively Killing Oral Cancer Cells by Generating ROS, DNA Damage, and Apoptotic PathwaysPLOS ONE, 2013
- Natural withanolides: an overviewNatural Product Reports, 2011
- Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS SignalingPLOS ONE, 2010